X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-07-03 | BCYC | Keen Nicholas | Chief Scientific Officer | S - Sale | $19.64 | -779 | 69,024 | -1% | -$15,300 | ||||||
2024-04-03 | BCYC | Keen Nicholas | Chief Scientific Officer | S - Sale | $23.81 | -790 | 69,803 | -1% | -$18,810 | ||||||
| D | 2024-01-03 | BCYC | Keen Nicholas | Chief Scientific Officer | S - Sale+OE | $17.50 | -2,640 | 70,593 | -4% | -$46,200 | |||||
2023-10-03 | BCYC | Keen Nicholas | Chief Scientific Officer | S - Sale | $20.00 | -272 | 45,233 | -1% | -$5,440 | ||||||
2023-07-03 | BCYC | Keen Nicholas | Chief Scientific Officer | S - Sale | $25.10 | -336 | 45,505 | -1% | -$8,434 | ||||||
2023-04-03 | BCYC | Keen Nicholas | Chief Scientific Officer | S - Sale | $21.11 | -319 | 45,841 | -1% | -$6,734 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |